SAFETY, IMMUNOGENICITY AND DURABILITY OF A NOVEL MALARIA VACCINE CANDIDATE, R21 ADJUVANTED WITH AS01(B)
Venkatraman N., Bowyer G., Collins K., Angell-Manning P., Powlson J., Bliss C., Brendish N., Griffiths O., Poulton I., Moyle S., Berrie E., Green N., Mukhopadhyay E., Lievens M., Morelle D., Lawrie A., Roberts R., Faust S., Ewer K., Hill AV.